Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus

ClinicalTrials.gov ID: NCT03742037

Public ClinicalTrials.gov record NCT03742037. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 11:38 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Cenerimod in Subjects With Moderate to Severe Systemic Lupus Erythematosus (SLE)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to assess the efficacy and safety of 4 doses of cenerimod versus placebo in adult subjects with systemic lupus erythematosus (SLE).

Study identification

NCT ID
NCT03742037
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Viatris Innovation GmbH
Industry
Enrollment
427 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 20, 2018
Primary completion
Aug 30, 2021
Completion
Aug 24, 2022
Last update posted
Jul 28, 2026

2018 – 2022

United States locations

U.S. sites
29
U.S. states
14
U.S. cities
28
Facility City State ZIP Site status
Pinnacle Research Group Anniston Alabama 36207
University of California San Diego La Jolla California 92037-0493
Valerius Medical Group and Research Center Los Alamitos California 90720-5403
University of Colorado School of Medicine Aurora Colorado 80045
Robert W Levin MD PA Clearwater Florida 33765
Center for Rheumatology Immunology and Arthritis Fort Lauderdale Florida 33309
Life Clinical Trials Margate Florida 33063
D&H National Research Centers INC Miami Florida 33155
San Marcus Research Clinic Miami Lakes Florida 33014
Millennium Research Ormond Beach Florida 32174-1139
Integral Rheumatology & Immunology Specialists Plantation Florida 33324
Advanced Research Institute Inc Allergy & Rheumatology St. Petersburg Florida 33708
Axiom Clinical Research of Florida Tampa Florida 33603
North Georgia Rheumatology Group - Duluth Lawrenceville Georgia 30046
Institute of Arthritis Research Idaho Falls Idaho 83404
Washington University School of Medicine St Louis Missouri 63110
Innovative Health Research Las Vegas Nevada 89128
New York Presbyterian Columbia University Medical Center New York New York 10032
State University of New York Upstate Medical University Syracuse New York 13210
Joint Muscle Medical Care and Research Institute - Lilington Office Charlotte North Carolina 28204
DJL Clinical Research Charlotte North Carolina 28210
Paramount Medical Research and Consulting Middleburg Heights Ohio 44130
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
Office of Ramesh C. Gupta, MD Memphis Tennessee 38119
Amarillo Center for Clinical Research Amarillo Texas 79124
Accurate Clinical Research Houston Texas 77034
Southwest Rheumatology Research, LLC Mesquite Texas 75150
Sun Research Institute San Antonio Texas 78215
Accurate Clinical Management Stafford Texas 77477

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 119 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03742037, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 28, 2026 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03742037 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →